Prestige Biologics Co., Ltd. (KOSDAQ:334970)

Prestige Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 29, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	185,051	283,797	245,391	272,542	184,546	453,181
Market Cap Growth	-39.64%	15.65%	-9.96%	47.68%	-59.28%	-
Enterprise Value	268,415	364,568	378,645	369,331	283,846	447,789
Last Close Price	2380.00	3650.00	3990.00	4460.00	3020.00	9600.00
PS Ratio	9.62	22.64	113.13	156.11	11855.95	140.44
PB Ratio	1.62	2.10	3.42	2.73	1.57	4.24
P/TBV Ratio	1.65	2.12	3.46	2.76	1.58	4.31
EV/Sales Ratio	13.95	29.09	174.57	211.55	18235.34	138.77
Debt / Equity Ratio	0.74	0.68	2.41	1.60	1.01	0.73
Net Debt / Equity Ratio	0.73	0.67	2.00	1.15	0.88	0.39
Net Debt / EBITDA Ratio	-4.09	-4.36	-6.47	-3.62	-3.60	-1.80
Net Debt / FCF Ratio	-17.44	-3.82	-8.51	-1.90	-0.87	-0.34
Asset Turnover	0.07	0.05	0.01	-	0	0.03
Inventory Turnover	1.22	1.28	0.89	-	0.00	0.14
Quick Ratio	0.06	0.06	0.34	0.53	0.54	1.59
Current Ratio	0.32	0.40	0.60	0.79	0.92	1.93
Return on Equity (ROE)	-22.14%	-26.55%	-34.26%	-	-44.30%	-74.70%
Return on Assets (ROA)	-7.76%	-7.52%	-7.02%	-	-9.85%	-13.05%
Return on Capital Employed (ROCE)	-24.60%	-20.10%	-17.00%	-18.50%	-16.20%	-15.00%
Earnings Yield	-15.26%	-9.68%	-11.97%	-14.47%	-26.94%	-8.69%
FCF Yield	-2.58%	-8.29%	-6.87%	-22.11%	-64.36%	-27.17%
Buyback Yield / Dilution	-34.27%	-20.50%	-4.32%	-13.35%	-16.43%	-25.46%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.